Confirm delete?

Bertin Bioreagent
logo
All categories
Contact Us
You are here :

Adenosine Receptor A2A Blocking Peptide

  • Photo non disponible
Cat No: 10092
Antibodies - Blocking Peptides
Cayman
€141.00
Price is excluding VAT and does not include packaging neither shipping

Adenosine Receptor A2A is a multi-pass membrane protein that is normally localized to the plasma membrane.{15465} This receptor is part of the G-protein coupled receptor family that binds adenosine and keeps it in equilibrium inside and outside the ce...

More
: 200 µg

This product can only be bought through Cayman Chemical. Please contact us.

- +
Territorial Availability: Available through Bertin Pharma only in Europe
Correlated keywords:
  • blocking peptides Western blots immunoblotting ARA2A
Product Overview:
Adenosine Receptor A2A is a multi-pass membrane protein that is normally localized to the plasma membrane.{15465} This receptor is part of the G-protein coupled receptor family that binds adenosine and keeps it in equilibrium inside and outside the cell. Along with establishing this equilibrium, A2AR serves multiple functions and antagonists of this receptor have been targeted for the treatment of Parkinson’s disease.{15466,5049} This protein is primarily found in the striatum, but can also be found in immune cells and other tissues as well.{15466} A2AR is 412 amino acids long with an expected molecular weight of 45 kDa. The receptor also has multiple glycosylation sites that explain the higher band shift seen in western blotting.{15465}
Size 200 µg
Shipping dry ice
Stability Store at -20 degrees; shelf life 365 days
Antigen human adenosine receptor a2A amino acids 213 – 220
Formulation 200 µg of peptide in 200 µl of TBS, pH 7.4, containing 0.1% BSA and 0.02% sodium azide
Custom Code 3504.00
UNSPSC code 12352203

Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.

Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.

Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.

/ We also advise you

Cross selling for this product : Adenosine Receptor A<sub>2A</sub> Blocking Peptide There are 9 products.

Search